Open Access
Research Paper
Peer Reviewed

Paper Title

Effect of Annona Muricata on CD8 and Granzyme-b Expression in Severe Plasmodium berghei Anka Infected Swiss Mice

Article Identifiers

Registration ID: IJNRD_180329

Published ID: IJNRD2008038

: Click Here to Get

About Hard Copy and Transparent Peer Review Report

Keywords

Annona muricata, P. berghei Anka, granzyme B, CD8

Abstract

Several studies have reported the role of T cells in Plasmodium berghei ANKA (PbA) that related with the blood and liver patology. Granzyme B (GzmB) is a serine protease released by CD8+ T cells and natural killer cells during cellular immune response, The purpose of these study to determine the effect of Annona muricata leaf-ethanolic exract (AME) on GzmB and CD8-expression-score in spleens of PbA-infected-Swiss-mice. This experimental study used randomized post test only control group design. Thirty six female Swiss mice were divided into 6 groups. C1-group was control-healthy mice, G1 and G2-groups were healthy-mice treated with AME dosage 100 and 150 mg/kg BW/day for 14-day-period. C2-group was control-PbA-infected-group. G3 and G4-groups received AME dosage 100 and 150 mg/kg BW, respectively for 7-day-pre and post-PbA-infection. GzmB and CD8 in the spleen stained by immunohistochemistry-method, then two-pathology-anatomy-experts determined Allred-score by using light microscope. Statistical analyzes used were One-way-ANOVA-test followed by post-hoc-test, and. Pearson-correlation-test. G4 and C1-groups had no significant different GzmB-expression-score (5.60 ± 0.46 and 4.10 ± 1.27; p = 0.134), while those of G3 and C2-groups (6.03 ± 0.48 and 6.70 ± 0.99) were significantly higher than C1-group (p = 0.015 and p = 0.012). AME (150mg/kg BW/day)-treatment associated with GzmB-expression-normal score during severe-PbA-infection. G3, G4 and C2-groups (5.03 ± 0.79; 6.20 ± 1.46 and 6.60 ± 2.77) had no significant different CD8-expression-score compare to C1-group (3.80 ± 2.60; p = 0.829; p = 0.284 and p = 0.150). The correlation score of GzmB and CD8 expression was not found in healthy Swiss mice infected with PbA (r = -0.248; p = 0.158). AME in dose of 150 mg/kg BW/day-treatment normalize GzmB-expression-score of severe-PbA-infected-Swiss-mice, however AME at any dose studied have no influence on CD8- expression-score of those mice

How To Cite (APA)

Abdulkarim Abdullah Mohammed Amammish, Kis Djamiatun, Muflihatul Muniroh, & Dik Puspasari (August-2020). Effect of Annona Muricata on CD8 and Granzyme-b Expression in Severe Plasmodium berghei Anka Infected Swiss Mice. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 5(8), 338-346. https://ijnrd.org/papers/IJNRD2008038.pdf

Issue

Other Publication Details

Paper Reg. ID: IJNRD_180329

Published Paper Id: IJNRD2008038

Research Area: Medical Science

Author Type: Foreign Author

Country: Semarang, Indonesia, Indonesia

Published Paper PDF: https://ijnrd.org/papers/IJNRD2008038.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2008038

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International UGC CARE JOURNAL PUBLICATION, Low Cost, Scholarly Open Access, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Copyright & License

© 2026 - Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0). 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use. CC OpenContant

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 11 | Issue 4 | April 2026

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the New UGC CARE Transparent Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

Transparent Peer Review Journal Publication: IJNRD operates a strict double-blind peer review system managed by 3000+ expert reviewers, ensuring ethical, unbiased, and high-quality review for every research paper.

For Indian Authors : Get a transparent peer review report from Scholar9.com for just ₹1000. View Sample Report

For Foreign Authors : A detailed peer review report is available through Scholar9.com for $20 USD. View Sample Report


Transparent Peer Review Journal Publication


⭐ Transparent Peer Review | 🕵️‍♂️ Double-Blind | 👨‍🏫 3000+ Expert Reviewers | 🇮🇳 Report for India Author ₹1000 | 🌐 Report for Foreign Author $20 | 📄 Sample Reports on Scholar9.com | 🌍 High Credibility | ⚖️ Ethical & Unbiased Evaluation

How to submit the paper?

Recently, the UGC discontinued the UGC-CARE Journal List and introduced new parameters that allow publication in Transparent Peer-Reviewed (Refereed) Journals. IJNRD is Transparent Peer Review Journal Valid As per New UGC Notification.


You can now publish your research paper in IJNRD.ORG. IJNRD is a Transparent Peer-Reviewed Open Access (Refereed Journal), UGC and UGC CARE Approved, Crossref DOI, Multidisciplinary, Impact Factor calculate by Google Scholar. As an International, open-access, and online journal, Publishing with us ensures wider reach, academic credibility, and enhanced recognition for your work.


For more details, refer to the official notice: UGC Public Notice


⭐ Low Cost ₹1570 | 📚 UGC CARE Approved | 🔍 Peer-Reviewed | 🌐 Open Access | 🔗 Crossref DOI & Global Indexing | 📊 Google Scholar Impact Factor | 🧪 Multidisciplinary


Submit Paper Online  Call for Paper  About IJNRD UGC CARE Approval

Important Dates for Current issue

Paper Submission Open For: April 2026

Current Issue: Volume 11 | Issue 4 | April 2026

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-May-2026

Notification of Review Result: Transparent peer review process - your paper is evaluated by experts, and you receive acceptance or rejection updates via email and SMS.

Publication of Paper: Once all documents are submitted, your paper is published without delay, and you can instantly download your certificate and confirmation letter online.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an international open-access journal offering Low Cost Journal Publication, transparent Peer Review Journal Publication, Crossref DOI, and multidisciplinary research visibility under UGC CARE Approved Journal Publication.

Subject Category: Research Area

Approval, Licenses and Indexing: More Details


Call For Paper - Volume 11 | Issue 4 | April 2026


IJNRD.org offers low-cost journal publication starting at ₹1570 with UGC CARE Approved, refereed, peer-reviewed, open-access publishing. This multidisciplinary monthly journal, available in both online and print formats, features a strong Google Scholar-based impact factor of 8.76, Transparent Peer Review, CrossRef DOI, global indexing, fast publication, and complete metadata for maximum research visibility and citation impact across multidisciplinary domains.


Volume 11 | Issue 4 | April 2026 | IJNRD Transparent Peer Review Certificate | Submit Paper Online


⭐ UGC CARE Approved Refereed Journal | 🔍 Transparent Peer Review | 🌐 Open Access Publishing | 💰 Low-Cost ₹1570 | 🔗 CrossRef DOI & Global Indexing | 📊 Google Scholar Impact Factor 8.76 | 🧪 Multidisciplinary | Online & Print


Submit Paper Online